+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Hyperalgesia Drug"

Hyperalgesia - Pipeline Insight, 2024 - Product Thumbnail Image

Hyperalgesia - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Hyperalgesia - Pipeline Review, H2 2020 - Product Thumbnail Image

Hyperalgesia - Pipeline Review, H2 2020

  • Drug Pipelines
  • July 2020
  • 40 Pages
  • Global
From
  • 2 Results (Page 1 of 1)
Loading Indicator

Hyperalgesia is a condition in which a person experiences an increased sensitivity to pain. Analgesics are drugs used to reduce pain, and the Hyperalgesia Drug market is a subset of the Analgesics market that focuses on drugs specifically designed to treat hyperalgesia. These drugs are typically non-steroidal anti-inflammatory drugs (NSAIDs) or opioids, and they are used to reduce the intensity of pain signals sent to the brain. The Hyperalgesia Drug market is highly competitive, with many companies offering different types of drugs. Some of the major players in the market include Pfizer, GlaxoSmithKline, Merck & Co., Johnson & Johnson, Novartis, and AstraZeneca. Other companies in the market include Sanofi, Eli Lilly, Teva Pharmaceuticals, and Mylan. Show Less Read more